Roche Registration Ltd. | diagnosia.com

Roche Registration Ltd.

Address: -
Telephone: -
Fax: -
Web: -
Email: -
Corporate Phone: -

For Pharmacy Companies

Get your Diagnosia.com profile and a presence on europe's leading medical drug search.

Logo Upload your logo
Contact details Your full contact details
Branding Let your CI do the talking
Newsfeed Integrate your corporate news

More Information

Drugs produced by Roche Registration Ltd.

Avastin 25 mg/ml concentrate for solution for infusion
- admission:
  Great Britain
- Producer: Roche Registration Ltd.
- ATC-Code: L01XC07
Bondenza 150 mg film-coated tablets
- admission:
  Great Britain
- Producer: Roche Registration Ltd.
- ATC-Code: M05BA06
- Therapeutic Area: Osteoporosis
- Active Substance: Ibandronic Acid
Bondenza 3 mg solution for injection
- admission:
  Great Britain
- Producer: Roche Registration Ltd.
- ATC-Code: M05BA06
- Therapeutic Area: Osteoporosis
- Active Substance: Ibandronic Acid
Bonviva 150 mg film-coated tablets
- admission:
  Great Britain
- Producer: Roche Registration Ltd.
- ATC-Code: M05BA06
- Therapeutic Area: Osteoporosis
- Active Substance: Ibandronic Acid
Bonviva 3 mg solution for injection
- admission:
  Great Britain
- Producer: Roche Registration Ltd.
- ATC-Code: M05BA06
- Therapeutic Area: Osteoporosis
- Active Substance: Ibandronic Acid
CellCept 1 g/5 ml powder for oral suspension
- admission:
  Great Britain
- Producer: Roche Registration Ltd.
- ATC-Code: L04AA06
- Active Substance: Mycophenolate Mofetil
CellCept 250 mg capsules
- admission:
  Great Britain
- Producer: Roche Registration Ltd.
- ATC-Code: L04AA06
- Active Substance: Mycophenolate Mofetil
CellCept 500 mg powder for concentrate for solution for infusion
- admission:
  Great Britain
- Producer: Roche Registration Ltd.
- ATC-Code: L04AA06
- Active Substance: Mycophenolate Mofetil, Hydrochloride
CellCept 500 mg tablets
- admission:
  Great Britain
- Producer: Roche Registration Ltd.
- ATC-Code: L04AA06
- Active Substance: Mycophenolate Mofetil
Herceptin 150 mg powder for concentrate for solution for infusion
- admission:
  Great Britain
- Producer: Roche Registration Ltd.
- ATC-Code: L01XC03
- Active Substance: Trastuzumab
INVIRASE 200 mg hard capsules
- admission:
  Great Britain
- Producer: Roche Registration Ltd.
- ATC-Code: J05AE01
- Active Substance: Saquinavir
INVIRASE 500 mg film-coated tablets
- admission:
  Great Britain
- Producer: Roche Registration Ltd.
- ATC-Code: J05AE01
- Active Substance: Saquinavir
MabThera 100 mg concentrate for solution for infusion
- admission:
  Great Britain
- Producer: Roche Registration Ltd.
- ATC-Code: L01XC02
- Therapeutic Area: Leukemia, Arthritis, Lymphoma
- Active Substance: Rituximab
MabThera 500 mg concentrate for solution for infusion
- admission:
  Great Britain
- Producer: Roche Registration Ltd.
- ATC-Code: L01XC02
- Therapeutic Area: Leukemia, Arthritis, Lymphoma
- Active Substance: Rituximab
MIRCERA 100 micrograms/0.3 ml solution for injection in pre-filled syringe
- admission:
  Great Britain
- Producer: Roche Registration Ltd.
- ATC-Code: B03XA03
- Therapeutic Area: Anemia
- Active Substance: Methoxy Polyethylene Glycol-epoetin Beta, Epoetin Beta
MIRCERA 120 micrograms/0.3 ml solution for injection in pre-filled syringe
- admission:
  Great Britain
- Producer: Roche Registration Ltd.
- ATC-Code: B03XA03
- Therapeutic Area: Anemia
- Active Substance: Methoxy Polyethylene Glycol-epoetin Beta, Epoetin Beta
MIRCERA 150 micrograms/0.3 ml solution for injection in pre-filled syringe
- admission:
  Great Britain
- Producer: Roche Registration Ltd.
- ATC-Code: B03XA03
- Therapeutic Area: Anemia
- Active Substance: Methoxy Polyethylene Glycol-epoetin Beta, Epoetin Beta
MIRCERA 200 micrograms/0.3 ml solution for injection in pre-filled syringe
- admission:
  Great Britain
- Producer: Roche Registration Ltd.
- ATC-Code: B03XA03
- Therapeutic Area: Anemia
- Active Substance: Methoxy Polyethylene Glycol-epoetin Beta, Epoetin Beta
MIRCERA 250 micrograms/0.3 ml solution for injection in pre-filled syringe
- admission:
  Great Britain
- Producer: Roche Registration Ltd.
- ATC-Code: B03XA03
- Therapeutic Area: Anemia
- Active Substance: Methoxy Polyethylene Glycol-epoetin Beta, Epoetin Beta
MIRCERA 30 micrograms/0.3 ml solution for injection in pre-filled syringe
- admission:
  Great Britain
- Producer: Roche Registration Ltd.
- ATC-Code: B03XA03
- Therapeutic Area: Anemia
- Active Substance: Methoxy Polyethylene Glycol-epoetin Beta, Epoetin Beta
MIRCERA 360 micrograms/0.6 ml solution for injection in pre-filled syringe
- admission:
  Great Britain
- Producer: Roche Registration Ltd.
- ATC-Code: B03XA03
- Therapeutic Area: Anemia
- Active Substance: Methoxy Polyethylene Glycol-epoetin Beta, Epoetin Beta
MIRCERA 40 micrograms/0.3 ml solution for injection in pre-filled syringe
- admission:
  Great Britain
- Producer: Roche Registration Ltd.
- ATC-Code: B03XA03
- Therapeutic Area: Anemia
- Active Substance: Methoxy Polyethylene Glycol-epoetin Beta, Epoetin Beta
MIRCERA 50 micrograms/0.3 ml solution for injection in pre-filled syringe
- admission:
  Great Britain
- Producer: Roche Registration Ltd.
- ATC-Code: B03XA03
- Therapeutic Area: Anemia
- Active Substance: Methoxy Polyethylene Glycol-epoetin Beta, Epoetin Beta
MIRCERA 60 micrograms/0.3 ml solution for injection in pre-filled syringe
- admission:
  Great Britain
- Producer: Roche Registration Ltd.
- ATC-Code: B03XA03
- Therapeutic Area: Anemia
- Active Substance: Methoxy Polyethylene Glycol-epoetin Beta, Epoetin Beta
MIRCERA 75 micrograms/0.3 ml solution for injection in pre-filled syringe
- admission:
  Great Britain
- Producer: Roche Registration Ltd.
- ATC-Code: B03XA03
- Therapeutic Area: Anemia
- Active Substance: Methoxy Polyethylene Glycol-epoetin Beta, Epoetin Beta
NeoRecormon 1000 IU solution for injection in pre-filled syringe
- admission:
  Great Britain
- Producer: Roche Registration Ltd.
- ATC-Code: B03XA01
- Therapeutic Area: Anemia
- Active Substance: Epoetin Beta

Pages